Table 1 Comparison of variables in patients with SOS and control group

Age (years)

60.3 ± 10.6

60.5 (54.2–68.5)

52.9 ± 11.8

52.5 (48.2–59.7)

0.06**

Male/female

11/7

11/5

ALT (IU/L)

33.4 ± 23.3

28 (17.7–42.5)

32.2 ± 19.5

27 (21–32.5)

1*

AST (IU/L)

41 ± 19

35.5 (28.2–54.7)

30 ± 9.8

24 (22–35.5)

0.06*

ALP (IU/L)

208 ± 158

146.5 (105–219)

135 ± 31

135 (121–159)

0.34*

GGT (IU/L)

151.4 ± 57

66.5 (33.2–128.2)

85.6 ± 24

58 (34.5–85.5)

0.57*

Total bilirubin(mg/dL)

0.96 ± 0.3

1.07 (0.68–1.26)

0.67 ± 0.2

0.64 ( 0.5–0.78)

0.052*

Thrombocyte (10³/μl)

174 ± 47.4

176 (139.2–213.5)

187 ± 91

200 (179.5–212.5)

0.17*

MRE-LSM (kPa)

3.14 ± 0.45

3.01 (2.85–3.35)

2.62 ± 0.5

2.55 (2.28–2.75)

0.01**

cT1 (ms)

1181 ± 151

1141 (1095–1290)

1032 ± 129

1032 (1004–1092)

0.005**

T2 (ms)

50.2 ± 3.6

49 (48–52)

44.4 ± 2.7

45 (43.5–46)

0.01**

T2 star (ms)

35 ± 4.7

33 (32–40)

33.3 ± 4.8

33 (31–38)

0.3**

Liver fat fraction (%)

4.5 ± 3

3.5 (2.7–4.7)

7.2 ± 6

6.2 (2.7–8.2)

0.26*